Skip to main content
Erschienen in: Journal of Neurology 8/2021

24.02.2021 | Original Communication

Phenotypic and molecular diversities of spinocerebellar ataxia type 2 in Japan

verfasst von: Rino Inada, Makito Hirano, Nobuyuki Oka, Makoto Samukawa, Kazumasa Saigoh, Hidekazu Suzuki, Fukashi Udaka, Akihiro Hashiguchi, Hiroshi Takashima, Yukihiro Hamada, Yusaku Nakamura, Susumu Kusunoki

Erschienen in: Journal of Neurology | Ausgabe 8/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

We intended to clarify the phenotypic and molecular diversities of spinocerebellar ataxia type 2 (SCA2) in Japan.

Methods

DNA was extracted from the peripheral blood of 436 patients, including 126 patients with chronic neuropathy, 108 with amyotrophic lateral sclerosis, and 202 with cerebellar ataxia. We then PCR-amplified and sequenced the ATXN2 gene. The biopsied sural nerves of mutation-positive patients were subjected to light-microscopic and electron-microscopic analyses. Transfection analyses were performed using a Schwann cell line, IMS32.

Results

We found PCR-amplified products potentially corresponding to expanded CAG repeats in four patients. Two patients in the chronic neuropathy group had a full repeat expansion or an intermediate expansion (39 or 32 repeats), without limb ataxia. The sural nerve biopsy findings of the two patients included axonal neuropathy and mixed neuropathy (axonal changes with demyelination). Schwann cells harbored either cytoplasmic or nuclear inclusions on electron microscopic examination. Both patients recently exhibited pyramidal signs. In the third patient in the cerebellar ataxia group, we identified a novel 21-base duplication mutation near 22 CAG repeats (c.432_452dup). The transfection study revealed that the 21-base-duplication mutant Ataxin-2 proteins aggregated in IMS32 and rendered cells susceptible to oxidative stress, similar to a CAG-expanded mutant. The fourth patient, with 41 repeats, had ataxia and spasticity. The two patients with cerebellar ataxia also had peripheral neuropathy.

Conclusions

Patients with expanded CAG repeats can exhibit a neuropathy-dominant phenotype not described previously. The novel 21-base-duplication mutant seems to share the aggregation properties of polyglutamine-expanded mutants.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Sanpei K, Takano H, Igarashi S, Sato T, Oyake M, Sasaki H, Wakisaka A, Tashiro K, Ishida Y, Ikeuchi T, Koide R, Saito M, Sato A, Tanaka T, Hanyu S, Takiyama Y, Nishizawa M, Shimizu N, Nomura Y, Segawa M, Iwabuchi K, Eguchi I, Tanaka H, Takahashi H, Tsuji S (1996) Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet 14:277–284CrossRef Sanpei K, Takano H, Igarashi S, Sato T, Oyake M, Sasaki H, Wakisaka A, Tashiro K, Ishida Y, Ikeuchi T, Koide R, Saito M, Sato A, Tanaka T, Hanyu S, Takiyama Y, Nishizawa M, Shimizu N, Nomura Y, Segawa M, Iwabuchi K, Eguchi I, Tanaka H, Takahashi H, Tsuji S (1996) Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet 14:277–284CrossRef
2.
Zurück zum Zitat Naruse H, Matsukawa T, Ishiura H, Mitsui J, Takahashi Y, Takano H, Goto J, Toda T, Tsuji S (2019) Association of ATXN2 intermediate-length CAG repeats with amyotrophic lateral sclerosis correlates with the distributions of normal CAG repeat alleles among individual ethnic populations. Neurogenetics 20:65–71CrossRef Naruse H, Matsukawa T, Ishiura H, Mitsui J, Takahashi Y, Takano H, Goto J, Toda T, Tsuji S (2019) Association of ATXN2 intermediate-length CAG repeats with amyotrophic lateral sclerosis correlates with the distributions of normal CAG repeat alleles among individual ethnic populations. Neurogenetics 20:65–71CrossRef
3.
Zurück zum Zitat Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM, Padmanabhan A, Clay-Falcone D, McCluskey L, Elman L, Juhr D, Gruber PJ, Rub U, Auburger G, Trojanowski JQ, Lee VM, Van Deerlin VM, Bonini NM, Gitler AD (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466:1069–1075CrossRef Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM, Padmanabhan A, Clay-Falcone D, McCluskey L, Elman L, Juhr D, Gruber PJ, Rub U, Auburger G, Trojanowski JQ, Lee VM, Van Deerlin VM, Bonini NM, Gitler AD (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466:1069–1075CrossRef
4.
Zurück zum Zitat Gwinn-Hardy K, Chen JY, Liu HC, Liu TY, Boss M, Seltzer W, Adam A, Singleton A, Koroshetz W, Waters C, Hardy J, Farrer M (2000) Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese. Neurology 55:800–805CrossRef Gwinn-Hardy K, Chen JY, Liu HC, Liu TY, Boss M, Seltzer W, Adam A, Singleton A, Koroshetz W, Waters C, Hardy J, Farrer M (2000) Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese. Neurology 55:800–805CrossRef
5.
Zurück zum Zitat Baumer D, East SZ, Tseu B, Zeman A, Hilton D, Talbot K, Ansorge O (2014) FTLD-ALS of TDP-43 type and SCA2 in a family with a full ataxin-2 polyglutamine expansion. Acta Neuropathol 128:597–604CrossRef Baumer D, East SZ, Tseu B, Zeman A, Hilton D, Talbot K, Ansorge O (2014) FTLD-ALS of TDP-43 type and SCA2 in a family with a full ataxin-2 polyglutamine expansion. Acta Neuropathol 128:597–604CrossRef
6.
Zurück zum Zitat Tazen S, Figueroa K, Kwan JY, Goldman J, Hunt A, Sampson J, Gutmann L, Pulst SM, Mitsumoto H, Kuo SH (2013) Amyotrophic lateral sclerosis and spinocerebellar ataxia type 2 in a family with full CAG repeat expansions of ATXN2. JAMA Neurol 70:1302–1304PubMedPubMedCentral Tazen S, Figueroa K, Kwan JY, Goldman J, Hunt A, Sampson J, Gutmann L, Pulst SM, Mitsumoto H, Kuo SH (2013) Amyotrophic lateral sclerosis and spinocerebellar ataxia type 2 in a family with full CAG repeat expansions of ATXN2. JAMA Neurol 70:1302–1304PubMedPubMedCentral
7.
Zurück zum Zitat Perretti A, Santoro L, Lanzillo B, Filla A, De Michele G, Barbieri F, Martino G, Ragno M, Cocozza S, Caruso G (1996) Autosomal dominant cerebellar ataxia type I: multimodal electrophysiological study and comparison between SCA1 and SCA2 patients. J Neurol Sci 142:45–53CrossRef Perretti A, Santoro L, Lanzillo B, Filla A, De Michele G, Barbieri F, Martino G, Ragno M, Cocozza S, Caruso G (1996) Autosomal dominant cerebellar ataxia type I: multimodal electrophysiological study and comparison between SCA1 and SCA2 patients. J Neurol Sci 142:45–53CrossRef
8.
Zurück zum Zitat Filla A, De Michele G, Campanella G, Perretti A, Santoro L, Serlenga L, Ragno M, Calabrese O, Castaldo I, De Joanna G, Cocozza S (1996) Autosomal dominant cerebellar ataxia type I. Clinical and molecular study in 36 Italian families including a comparison between SCA1 and SCA2 phenotypes. J Neurol Sci 142:140–147CrossRef Filla A, De Michele G, Campanella G, Perretti A, Santoro L, Serlenga L, Ragno M, Calabrese O, Castaldo I, De Joanna G, Cocozza S (1996) Autosomal dominant cerebellar ataxia type I. Clinical and molecular study in 36 Italian families including a comparison between SCA1 and SCA2 phenotypes. J Neurol Sci 142:140–147CrossRef
9.
Zurück zum Zitat Malandrini A, Galli L, Villanova M, Palmeri S, Parrotta E, DeFalco D, Cappelli M, Grieco GS, Renieri A, Guazzi G (1998) CAG repeat expansion in an italian family with spinocerebellar ataxia type 2 (SCA2): a clinical and genetic study. Eur Neurol 40:164–168CrossRef Malandrini A, Galli L, Villanova M, Palmeri S, Parrotta E, DeFalco D, Cappelli M, Grieco GS, Renieri A, Guazzi G (1998) CAG repeat expansion in an italian family with spinocerebellar ataxia type 2 (SCA2): a clinical and genetic study. Eur Neurol 40:164–168CrossRef
10.
Zurück zum Zitat Stezin A, Venkatesh SD, Thennarasu K, Purushottam M, Jain S, Yadav R, Pal PK (2018) Non-ataxic manifestations of Spinocerebellar ataxia-2, their determinants and predictors. J Neurol Sci 394:14–18CrossRef Stezin A, Venkatesh SD, Thennarasu K, Purushottam M, Jain S, Yadav R, Pal PK (2018) Non-ataxic manifestations of Spinocerebellar ataxia-2, their determinants and predictors. J Neurol Sci 394:14–18CrossRef
11.
Zurück zum Zitat Higuchi Y, Hashiguchi A, Yuan J, Yoshimura A, Mitsui J, Ishiura H, Tanaka M, Ishihara S, Tanabe H, Nozuma S, Okamoto Y, Matsuura E, Ohkubo R, Inamizu S, Shiraishi W, Yamasaki R, Ohyagi Y, Kira J, Oya Y, Yabe H, Nishikawa N, Tobisawa S, Matsuda N, Masuda M, Kugimoto C, Fukushima K, Yano S, Yoshimura J, Doi K, Nakagawa M, Morishita S, Tsuji S, Takashima H (2016) Mutations in MME cause an autosomal-recessive Charcot-Marie-Tooth disease type 2. Ann Neurol 79:659–672 Higuchi Y, Hashiguchi A, Yuan J, Yoshimura A, Mitsui J, Ishiura H, Tanaka M, Ishihara S, Tanabe H, Nozuma S, Okamoto Y, Matsuura E, Ohkubo R, Inamizu S, Shiraishi W, Yamasaki R, Ohyagi Y, Kira J, Oya Y, Yabe H, Nishikawa N, Tobisawa S, Matsuda N, Masuda M, Kugimoto C, Fukushima K, Yano S, Yoshimura J, Doi K, Nakagawa M, Morishita S, Tsuji S, Takashima H (2016) Mutations in MME cause an autosomal-recessive Charcot-Marie-Tooth disease type 2. Ann Neurol 79:659–672
12.
Zurück zum Zitat Hirano M, Nakamura Y, Saigoh K, Sakamoto H, Ueno S, Isono C, Mitsui Y, Kusunoki S (2015) VCP gene analyses in Japanese patients with sporadic amyotrophic lateral sclerosis identify a new mutation. Neurobiol Aging 36(1604):e1601-1606 Hirano M, Nakamura Y, Saigoh K, Sakamoto H, Ueno S, Isono C, Mitsui Y, Kusunoki S (2015) VCP gene analyses in Japanese patients with sporadic amyotrophic lateral sclerosis identify a new mutation. Neurobiol Aging 36(1604):e1601-1606
13.
Zurück zum Zitat Hirano M, Nakamura Y, Saigoh K, Sakamoto H, Ueno S, Isono C, Miyamoto K, Akamatsu M, Mitsui Y, Kusunoki S (2013) Mutations in the gene encoding p62 in Japanese patients with amyotrophic lateral sclerosis. Neurology 80:458–463CrossRef Hirano M, Nakamura Y, Saigoh K, Sakamoto H, Ueno S, Isono C, Miyamoto K, Akamatsu M, Mitsui Y, Kusunoki S (2013) Mutations in the gene encoding p62 in Japanese patients with amyotrophic lateral sclerosis. Neurology 80:458–463CrossRef
14.
Zurück zum Zitat Hirano M, Samukawa M, Isono C, Saigoh K, Nakamura Y, Kusunoki S (2018) Noncoding repeat expansions for ALS in Japan are associated with the ATXN8OS gene. Neurol Genet 4:e252CrossRef Hirano M, Samukawa M, Isono C, Saigoh K, Nakamura Y, Kusunoki S (2018) Noncoding repeat expansions for ALS in Japan are associated with the ATXN8OS gene. Neurol Genet 4:e252CrossRef
15.
Zurück zum Zitat Okazaki M, Suzuki H, Takahashi Y, Ishiura H, Goto J, Hirano M, Saigoh K, Nakamura Y, Naruse H, Mitsui J, Tsuji S, Kusunoki S (2017) Novel mutation in the SOD1 gene in a patient with early-onset, rapidly progressive amyotrophic lateral sclerosis. Neurol Clin Neurosci 5:189–191CrossRef Okazaki M, Suzuki H, Takahashi Y, Ishiura H, Goto J, Hirano M, Saigoh K, Nakamura Y, Naruse H, Mitsui J, Tsuji S, Kusunoki S (2017) Novel mutation in the SOD1 gene in a patient with early-onset, rapidly progressive amyotrophic lateral sclerosis. Neurol Clin Neurosci 5:189–191CrossRef
16.
Zurück zum Zitat Hirano M, Matsumura R, Nakamura Y, Saigoh K, Sakamoto H, Ueno S, Inoue H, Kusunoki S (2017) Unexpectedly mild phenotype in an ataxic family with a two-base deletion in the APTX gene. J Neurol Sci 378:75–79CrossRef Hirano M, Matsumura R, Nakamura Y, Saigoh K, Sakamoto H, Ueno S, Inoue H, Kusunoki S (2017) Unexpectedly mild phenotype in an ataxic family with a two-base deletion in the APTX gene. J Neurol Sci 378:75–79CrossRef
17.
Zurück zum Zitat Zhao Z, Hashiguchi A, Hu J, Sakiyama Y, Okamoto Y, Tokunaga S, Zhu L, Shen H, Takashima H (2012) Alanyl-tRNA synthetase mutation in a family with dominant distal hereditary motor neuropathy. Neurology 78:1644–1649CrossRef Zhao Z, Hashiguchi A, Hu J, Sakiyama Y, Okamoto Y, Tokunaga S, Zhu L, Shen H, Takashima H (2012) Alanyl-tRNA synthetase mutation in a family with dominant distal hereditary motor neuropathy. Neurology 78:1644–1649CrossRef
18.
Zurück zum Zitat Oka N, Kawasaki T, Unuma T, Shigematsu K, Sugiyama H (2013) Different profiles of onion bulb in CIDP and CMT1A in relation to extracellular matrix. Clin Neuropathol 32:406–412CrossRef Oka N, Kawasaki T, Unuma T, Shigematsu K, Sugiyama H (2013) Different profiles of onion bulb in CIDP and CMT1A in relation to extracellular matrix. Clin Neuropathol 32:406–412CrossRef
19.
Zurück zum Zitat Watabe K, Fukuda T, Tanaka J, Honda H, Toyohara K, Sakai O (1995) Spontaneously immortalized adult mouse Schwann cells secrete autocrine and paracrine growth-promoting activities. J Neurosci Res 41:279–290CrossRef Watabe K, Fukuda T, Tanaka J, Honda H, Toyohara K, Sakai O (1995) Spontaneously immortalized adult mouse Schwann cells secrete autocrine and paracrine growth-promoting activities. J Neurosci Res 41:279–290CrossRef
20.
Zurück zum Zitat Linnemann C, Tezenas du Montcel S, Rakowicz M, Schmitz-Hubsch T, Szymanski S, Berciano J, van de Warrenburg BP, Pedersen K, Depondt C, Rola R, Klockgether T, Garcia A, Mutlu G, Schols L (2016) Peripheral Neuropathy in Spinocerebellar ataxia Type 1, 2, 3, and 6. Cerebellum 15:165–173CrossRef Linnemann C, Tezenas du Montcel S, Rakowicz M, Schmitz-Hubsch T, Szymanski S, Berciano J, van de Warrenburg BP, Pedersen K, Depondt C, Rola R, Klockgether T, Garcia A, Mutlu G, Schols L (2016) Peripheral Neuropathy in Spinocerebellar ataxia Type 1, 2, 3, and 6. Cerebellum 15:165–173CrossRef
21.
Zurück zum Zitat Schroder JM, Sommer C (1991) Mitochondrial abnormalities in human sural nerves: fine structural evaluation of cases with mitochondrial myopathy, hereditary and non-hereditary neuropathies, and review of the literature. Acta Neuropathol 82:471–482CrossRef Schroder JM, Sommer C (1991) Mitochondrial abnormalities in human sural nerves: fine structural evaluation of cases with mitochondrial myopathy, hereditary and non-hereditary neuropathies, and review of the literature. Acta Neuropathol 82:471–482CrossRef
22.
Zurück zum Zitat Yasaki S, Tukamoto Y, Yuasa N, Ohnuki T, Yoshii F (2016) Possible coexisting autoimmunity in a variant case of familial amyotrophic lateral sclerosis associated with anti-GM2 immunoglobulin M antibody. Neurol Clin Neurosci 4:118–120CrossRef Yasaki S, Tukamoto Y, Yuasa N, Ohnuki T, Yoshii F (2016) Possible coexisting autoimmunity in a variant case of familial amyotrophic lateral sclerosis associated with anti-GM2 immunoglobulin M antibody. Neurol Clin Neurosci 4:118–120CrossRef
23.
Zurück zum Zitat Berciano J, Ferrer I (2005) Glial cell cytoplasmic inclusions in SCA2 do not express alpha-synuclein. J Neurol 252:742–744CrossRef Berciano J, Ferrer I (2005) Glial cell cytoplasmic inclusions in SCA2 do not express alpha-synuclein. J Neurol 252:742–744CrossRef
24.
Zurück zum Zitat Ettle B, Schlachetzki JCM, Winkler J (2016) Oligodendroglia and myelin in neurodegenerative diseases: more than just bystanders? Mol Neurobiol 53:3046–3062CrossRef Ettle B, Schlachetzki JCM, Winkler J (2016) Oligodendroglia and myelin in neurodegenerative diseases: more than just bystanders? Mol Neurobiol 53:3046–3062CrossRef
25.
Zurück zum Zitat Adachi H, Katsuno M, Minamiyama M, Waza M, Sang C, Nakagomi Y, Kobayashi Y, Tanaka F, Doyu M, Inukai A, Yoshida M, Hashizume Y, Sobue G (2005) Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients. Brain 128:659–670CrossRef Adachi H, Katsuno M, Minamiyama M, Waza M, Sang C, Nakagomi Y, Kobayashi Y, Tanaka F, Doyu M, Inukai A, Yoshida M, Hashizume Y, Sobue G (2005) Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients. Brain 128:659–670CrossRef
26.
Zurück zum Zitat Huynh DP, Figueroa K, Hoang N, Pulst SM (2000) Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human. Nat Genet 26:44–50CrossRef Huynh DP, Figueroa K, Hoang N, Pulst SM (2000) Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human. Nat Genet 26:44–50CrossRef
27.
Zurück zum Zitat Koyano S, Yagishita S, Kuroiwa Y, Tanaka F, Uchihara T (2014) Neuropathological staging of spinocerebellar ataxia type 2 by semiquantitative 1C2-positive neuron typing. Nuclear translocation of cytoplasmic 1C2 underlies disease progression of spinocerebellar ataxia type 2. Brain Pathol 24:599–606CrossRef Koyano S, Yagishita S, Kuroiwa Y, Tanaka F, Uchihara T (2014) Neuropathological staging of spinocerebellar ataxia type 2 by semiquantitative 1C2-positive neuron typing. Nuclear translocation of cytoplasmic 1C2 underlies disease progression of spinocerebellar ataxia type 2. Brain Pathol 24:599–606CrossRef
28.
Zurück zum Zitat Corrado L, Mazzini L, Oggioni GD, Luciano B, Godi M, Brusco A, D’Alfonso S (2011) ATXN-2 CAG repeat expansions are interrupted in ALS patients. Hum Genet 130:575–580CrossRef Corrado L, Mazzini L, Oggioni GD, Luciano B, Godi M, Brusco A, D’Alfonso S (2011) ATXN-2 CAG repeat expansions are interrupted in ALS patients. Hum Genet 130:575–580CrossRef
29.
Zurück zum Zitat Laffita-Mesa JM, Rodriguez Pupo JM, Moreno Sera R, Vazquez Mojena Y, Kouri V, Laguna-Salvia L, Martinez-Godales M, Valdevila Figueira JA, Bauer PO, Rodriguez-Labrada R, Gonzalez Zaldivar Y, Paucar M, Svenningsson P, Velazquez Perez L (2013) De novo mutations in ataxin-2 gene and ALS risk. PLoS ONE 8:e70560CrossRef Laffita-Mesa JM, Rodriguez Pupo JM, Moreno Sera R, Vazquez Mojena Y, Kouri V, Laguna-Salvia L, Martinez-Godales M, Valdevila Figueira JA, Bauer PO, Rodriguez-Labrada R, Gonzalez Zaldivar Y, Paucar M, Svenningsson P, Velazquez Perez L (2013) De novo mutations in ataxin-2 gene and ALS risk. PLoS ONE 8:e70560CrossRef
30.
Zurück zum Zitat Van Damme P, Veldink JH, van Blitterswijk M, Corveleyn A, van Vught PW, Thijs V, Dubois B, Matthijs G, van den Berg LH, Robberecht W (2011) Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2. Neurology 76:2066–2072CrossRef Van Damme P, Veldink JH, van Blitterswijk M, Corveleyn A, van Vught PW, Thijs V, Dubois B, Matthijs G, van den Berg LH, Robberecht W (2011) Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2. Neurology 76:2066–2072CrossRef
31.
Zurück zum Zitat Isak B, Tankisi H, Johnsen B, Pugdahl K, Torvin MA, Finnerup NB, Christensen PB, Fuglsang-Frederiksen A (2016) Involvement of distal sensory nerves in amyotrophic lateral sclerosis. Muscle Nerve 54:1086–1092CrossRef Isak B, Tankisi H, Johnsen B, Pugdahl K, Torvin MA, Finnerup NB, Christensen PB, Fuglsang-Frederiksen A (2016) Involvement of distal sensory nerves in amyotrophic lateral sclerosis. Muscle Nerve 54:1086–1092CrossRef
Metadaten
Titel
Phenotypic and molecular diversities of spinocerebellar ataxia type 2 in Japan
verfasst von
Rino Inada
Makito Hirano
Nobuyuki Oka
Makoto Samukawa
Kazumasa Saigoh
Hidekazu Suzuki
Fukashi Udaka
Akihiro Hashiguchi
Hiroshi Takashima
Yukihiro Hamada
Yusaku Nakamura
Susumu Kusunoki
Publikationsdatum
24.02.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 8/2021
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-021-10467-z

Weitere Artikel der Ausgabe 8/2021

Journal of Neurology 8/2021 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.